TARKA LP 240 mg/4 mg, extended-release film-coated tablet 90 tablets
Active ingredients: Verapamil hydrochloride, Trandolapril
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Extended-release film-coated tablet90 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- TARKA LP 240 mg/4 mg, comprimé pelliculé à libération prolongée
- Pharmaceutical form
- comprimé pelliculé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 90 comprimé(s)
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Sept 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60516982CIP73931710CIP133400939317106Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE VÉRAPAMILcomprimé | 240 mg · un comprimé | SA |
| TRANDOLAPRILcomprimé | 4 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.